KMTS
Kestra Medical Technologies, Ltd. Common StockKMTS
KMTS
–
Funds holding %
of 7,398 funds
0
Analysts bullish %
of 5 analysts
Fund manager confidence
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$24
2%
downside
Avg. target
$27
11%
upside
High target
$29
18%
upside
5 analyst ratings
4 positive
80%
1 neutral
20%
0 negative
0%
Wolfe Research Mike Polark 67% 1-year accuracy 8 / 12 met price target | 18%upside $29 | Outperform Initiated | 31 Mar 2025 |
Wells Fargo Larry Biegelsen 36% 1-year accuracy 17 / 47 met price target | 14%upside $28 | Overweight Initiated | 31 Mar 2025 |
Stifel Rick Wise 43% 1-year accuracy 15 / 35 met price target | 14%upside $28 | Buy Initiated | 31 Mar 2025 |
Goldman Sachs David Roman 30% 1-year accuracy 6 / 20 met price target | 2%downside $24 | Neutral Initiated | 31 Mar 2025 |
Piper Sandler Matt O'Brien 40% 1-year accuracy 20 / 50 met price target | 10%upside $27 | Overweight Initiated | 31 Mar 2025 |
Financial journalist opinion
Based on 5 articles about KMTS published over the past 30 days
Neutral
GlobeNewsWire
2 weeks ago
Kestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters' Over-Allotment Option in Initial Public Offering
KIRKLAND, Wash., March 14, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare company, announced today that the underwriters of Kestra's initial public offering exercised in full their previously disclosed over-allotment option and have purchased 1,782,352 shares of common stock at a public offering price of $17.00 per share. After giving effect to the sale of over-allotment option, the total number of shares sold by Kestra in the initial public offering was 13,664,704 and the total gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Kestra, were approximately $232 million. The issuance and sale of the over-allotment option closed today.
Positive
Seeking Alpha
3 weeks ago
Kestra Medical Technologies: A Potential Promising Public Offering
Kestra Medical Technologies has seen rapid growth but incurs substantial operating losses, making its valuation exercise a hard one. The company's Cardiac Recovery System, including the ASSURE WCD, addresses a significant market need for sudden cardiac arrest intervention. Despite strong product adoption and a large addressable market, risks include high losses, being a one-product business, and potential growth slowdown.
Neutral
GlobeNewsWire
3 weeks ago
Kestra Medical Technologies, Ltd. Announces Closing of Upsized Initial Public Offering
KIRKLAND, Wash., March 07, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) (“Kestra”), a wearable medical device and digital healthcare company, announced today the closing of its upsized initial public offering of 11,882,352 common shares at a public offering price of $17.00 per share. The total gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Kestra, were approximately $202 million. All of the common shares were offered by Kestra. Kestra's common shares began trading on the Nasdaq Global Select Market on March 6, 2025, under the ticker symbol "KMTS".
Positive
GeekWire
3 weeks ago
Kestra Medical Technologies raises $202M in IPO, prices shares above expected range
Kirkland, Wash.-based Kestra Medical Technologies raised $202 million in its initial public offering, pricing shares at $17.
Neutral
GlobeNewsWire
3 weeks ago
Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Initial Public Offering
KIRKLAND, Wash., March 05, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare company, today announced the pricing of its upsized initial public offering of 11,882,352 common shares at a public offering price of $17.00 per share.
Neutral
Seeking Alpha
1 month ago
U.S. IPO Weekly Recap: Small Asia-Based Names List, As TV Adtech MNTN And Others Join The Pipeline
Four IPOs and four SPACs listed this week. Four IPOs and two SPACs submitted initial filings. The March IPO market is set to start off with a quiet week.
Positive
GeekWire
1 month ago
Kestra Medical Technologies aims to raise $150M in IPO
Kirkland, Wash.-based Kestra Medical Technologies is aiming to raise about $150 million in its initial public offering, pricing shares between $14 and $16 on the Nasdaq, according to a new regulatory filing.
Neutral
GlobeNewsWire
1 month ago
Kestra Medical Technologies, Ltd. Announces Launch of Initial Public Offering
KIRKLAND, Wash., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare company, today announced the launch of its initial public offering of 10,000,000 common shares.
Neutral
Seeking Alpha
1 month ago
U.S. IPO Weekly Recap: IPO Calendar Slows Down With Small Listings
The calendar slowed down this past week, with only small listings in the US. There was one sizable filing this past week - AIRO Group Holdings. No IPOs are currently scheduled to list in the week ahead, although some small deals may list throughout it.
Neutral
Seeking Alpha
1 month ago
U.S. IPO Weekly Recap: Big Listings Post Mixed Results In Busy 7 IPO Week
Seven IPOs and three SPACs were listed this week. Seven IPOs and four SPACs submitted initial filings. Some small IPOs are tentatively scheduled for the short holiday week ahead.
Charts implemented using Lightweight Charts™